시장보고서
상품코드
1190731

정신건강용 신규 디바이스 및 플랫폼 시장 : 성장, 동향, COVID-19의 영향, 예측(2023-2028년)

Emerging Mental Health Devices and Platforms Market- Growth, Trends, and Forecasts (2023 - 2028)

발행일: | 리서치사: Mordor Intelligence | 페이지 정보: 영문 | 배송안내 : 2-3일 (영업일 기준)

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

정신건강용 신규 디바이스 및 플랫폼 시장은 예측 기간인 2022-2027년에 CAGR 23.1%를 기록할 것으로 예측됩니다.

목차

제1장 서론

  • 조사의 전제조건과 시장의 정의
  • 조사 대상 범위

제2장 조사 방법

제3장 주요 요약

제4장 시장 역학

  • 시장 개요
  • 시장 촉진요인
    • 원거리 상담(Teleconsultations)과 멘탈 지원 플랫폼의 수요 확대
    • 디지털 정신건강 환경에서 자금조달의 활발화
  • 시장 억제요인
    • 임상적으로 검증된 과학적 데이터의 한계
  • Porter's Five Forces 분석
    • 신규 진출업체의 위협
    • 구매자/소비자의 교섭력
    • 공급 기업의 교섭력
    • 대체품의 위협
    • 경쟁 기업간 경쟁 관계

제5장 시장 세분화(금액 기반 시장 규모 : 백만 달러)

  • 제품 유형별
    • 플랫폼
    • 디바이스
  • 애플리케이션별
    • 스트레스
    • 불안
    • 우울증
    • 조울증
    • 기타 용도
  • 지역
    • 북미
      • 미국
      • 캐나다
      • 멕시코
    • 유럽
      • 독일
      • 영국
      • 프랑스
      • 이탈리아
      • 스페인
      • 기타 유럽 지역
    • 아시아태평양
      • 중국
      • 일본
      • 인도
      • 호주
      • 한국
      • 기타 아시아태평양
    • 중동·아프리카
      • GCC
      • 남아프리카공화국
      • 기타 중동 지역
    • 남미 지역
      • 브라질
      • 아르헨티나
      • 기타 남미 지역

제6장 경쟁 구도

  • 기업 개요
    • Electromedical Products International, Inc.
    • Ginger
    • Happify Health
    • Headspace Inc.
    • Pear Therapeutics, Inc.
    • Quartet Health
    • Talkspace
    • Teladoc Health Inc.
    • Woebot Health
    • Clarigent Health
    • Feel Therapeutics Inc.

제7장 시장 기회 및 향후 전망

KSA 23.02.10

The emerging mental health devices and platforms market is expected to register a CAGR of 23.1% over the forecast period 2022-2027.

The emergence of COVID-19 is expected to have a significant impact on the emerging mental health devices and platforms market owing to the rise in mental health problems and the lack of closure of clinics and hospital facilities owing to the COVID-19. For instance, according to the June 2022 report of the World Health Organization, COVID-19 had a far-reaching effect on mental health and the number of people expressing psychological suffering as well as signs of post-traumatic stress disorder, anxiety, or despair has increased significantly. Also, as per the same source, there have been alarming indications of a wider prevalence of suicide ideas and actions, even in the healthcare industry. Further, the adoption of digital health services like telemedicine increased at a rapid pace during the pandemic, and thus, COVID-19 is expected to have a significant impact on the emerging mental health devices and platforms market.

The increase in teleconsultation after the pandemic and raising awareness of mental health during lockdowns were among the main factors driving the demand for mental health devices and platforms, thereby contributing to market growth. As per the press release in November 2021, Sun Life published the partnership with CloudMD to expand Mental Health Coach to all Group Benefits Clients. Even though many Canadians are suffering from mental health concerns, a Sun Life study found that more than half of them do not seek medical help. The biggest impediments to blame are cost, access, and feelings of embarrassment. With Mental Health Coach, Sun Life and CloudMD are bridging the gap. Clients who are at risk of having a mental health problem are identified through data analytics. It then proactively contacts clients to direct them to the appropriate resources and assistance.

Furthermore, the pandemic has brought attention to the importance of digital and virtual mental health care, potentially saving our mental health system. Product releases and strategic efforts by prominent market competitors favorably impact the industry's growth. For instance, in October 2021, Medical, Inc., a medical device company, announced that United States Food and Drug Administration (FDA) had granted the company Breakthrough Device Designation for its individualized, rapid-acting, non-invasive neurostimulation technology, which is intended to treat the major depressive disorder (MDD) in people who have not responded to antidepressant medication or other treatments. United States Food and Drug Administration (FDA) Breakthrough Device program aims to provide patients access to breakthrough technologies that have the potential to deliver more effective treatment or diagnosis for life-threatening or debilitating diseases or conditions than current medicines. Therefore, owing to the aforementioned factors, the studied market is anticipated to witness growth over the analysis period. However, the limited clinically validated scientific data for mental health applications restrain the market growth.

Key Market Trends

Mental Health Platforms are Expected to Occupy a Major Share in the Market Over the Forecast Period

Mental health platforms are digital platforms that strive to raise mental health awareness, de-stigmatize mental health issues, and provide treatment and therapy services. According to the reports published by Mental Health America 2022, the prevalence of mental illness ranked 1 in New Jersey. In addition, 19.86% of adults are experiencing a mental illness, equivalent to nearly 50 million Americans. The state prevalence of adult mental illness ranges from 16.37% in New Jersey to 26.86% in Utah. This increased prevalence accounts for the need for mental health platforms and device demand.

Moreover, the report published by Harvard Business Review in December 2020 under the title "Digital Tools Is Revolutionizing Mental Health Care in the U.S" rules out that virtual care and other digital tools are more important than ever in supporting existing care, expanding capacity, and giving scalability. In clinic-based virtual care, traditional in-person office visits are replaced with synchronous video or audio visits or asynchronous text messaging. This presents alternatives to the standard 50-minute therapy hour, allowing for better supply and demand matching across time zones and regions. Patients can text a clinician or coach at any time and receive a response later using asynchronous messaging through mental health platforms. As a result of the aforementioned factors, the mental health platforms segment is predicted to develop significantly throughout the forecast period.

North America is Anticipated to Occupy a Significant Share in the Mental Health Devices and Platforms Market

In 2021, North America held most of the market share for mental health platforms and devices. According to the 2020 report by the National Institute of Mental Health, nearly one in every five adults in United States suffers from a mental condition (52.9 million in 2020). The emergence of this region can be attributed to an increase in covid-19 in United States and the rest of North America, as well as enhanced governmental funding activities to improve mental health post-pandemic.

Key product releases, mergers and acquisitions, increased mental health awareness, and the presence of manufacturers in the country are all factors that have contributed to the growth of the mental health platforms and devices market. According to the press release on November 2021, by MindBeacon, one of North America's leading clinically-validated internet-based cognitive behavioral therapy solutions was acquired by CloudMD. The acquisition is predicted to be instantly synergistic because of several reasons such as the combined digital health platform providing a broad continuum of care to treat mild, moderate, acute, and chronic mental and physical care. Furthermore, In 2022, Texas-based medical equipment manufacturer Electromedical Products International, Inc. acquired Pulvinar Neuro (Pulvinar), a leading research-oriented medical device firm focused on the development of closed-loop and another novel neuromodulating brain stimulation solutions for the clinical treatment of various mental health disorders. Pulvinar's patented and exclusive technologies, such as transcranial alternating current stimulation (tACS), personalized feedback stimulation, and cloud-enabled digital medicines for the treatment of psychiatric and neurological disorders, will benefit from the acquisition. The analyzed market is predicted to grow in the North American region as a result of the above-mentioned factors.

Competitive Landscape

The emerging mental health devices and platforms market is fragmented in nature due to the presence of several companies operating globally as well as regionally. The competitive landscape includes an analysis of a few international and local companies that hold the market shares and are well known. Include TalkSpace, Headspace Inc., Pear Therapeutics, Inc., Happify Health, and Electromedical Products International, Inc., among others.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growing Demand for Teleconsultations and Mental Support Platforms
    • 4.2.2 Increased Funding Activity in Digital Mental Health Environment
  • 4.3 Market Restraints
    • 4.3.1 Limitation of Scientific Data that has been Clinically Validated
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Product Type
    • 5.1.1 Platforms
    • 5.1.2 Devices
  • 5.2 By Application
    • 5.2.1 Stress
    • 5.2.2 Anxiety
    • 5.2.3 Depression
    • 5.2.4 Bipolar Disorder
    • 5.2.5 Other Applications
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East and Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle East and Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Electromedical Products International, Inc.
    • 6.1.2 Ginger
    • 6.1.3 Happify Health
    • 6.1.4 Headspace Inc.
    • 6.1.5 Pear Therapeutics, Inc.
    • 6.1.6 Quartet Health
    • 6.1.7 Talkspace
    • 6.1.8 Teladoc Health Inc.
    • 6.1.9 Woebot Health
    • 6.1.10 Clarigent Health
    • 6.1.11 Feel Therapeutics Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제